July 26, 2017 / 8:42 PM / 3 months ago

BRIEF-FDA panel votes 22-1 against approving Intelli's opioid painkiller

July 26 (Reuters) - Intellipharmaceutics International Inc -

* FDA panel votes 22-1 against approving Intelli’s opioid painkiller

* FDA panel votes 4-19 to support claim that Intelli’s opioid painkiller has properties that can be expected to deter abuse by IV route of administration

* FDA panel votes unanimously against claim that there is sufficient data on intelli drug to include abuse-deterrent properties on label for IV route of administration Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below